Pilaralisib Completed Phase 2 Trials for Endometrial Cancer / Neoplasms, Endometrial Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01013324Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma